Due to COVID-19, new study enrollment is being assessed on a case by case basis. If you have any questions please call our central phone number at 616-391-1230.
We are a group of West Michigan hospitals, health care systems, physicians, and researchers working together to provide cancer education and access to new and unique cancer clinical trials.
Cancer Research Consortium of West Michigan, CRCWM, is a member of the National Cancer Institute Community Oncology Research Program (NCORP), 1 of only 32 in the country.
Cancer clinical trials are research studies to develop better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.
Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose or treat diseases.
Yes. Cancer clinical trials differ according to their primary purpose:
For more information, visit https://www.cancer.gov/about-cancer/treatment/clinical-trials/what-are-trials/types
Clinical trials give eligible participants the opportunity to:
To help you decide if you want to be in a study, U.S. Food and Drug Administration requires that you be given information about the study before you agree to take part. This is known as informed consent.
The research team provides an informed consent document that includes details about the study, such as its purpose, duration, required procedures, and key contacts, risks and potential benefits.The participant then decides whether or not to sign the document. Informed consent is not a contract, and the participant may withdraw from the trial at any time.